Company Profile

HandyLab Inc
Profile last edited on: 6/26/14      CAGE: 1YNJ7      UEI:

Business Identifier: molecular diagnostic assays and automation platforms
Year Founded
2000
First Award
2002
Latest Award
2003
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

5230 South State Road Suite 100
Ann Arbor, MI 48108
   (734) 663-4719
   info@handylab.com
   www.handylab.com
Location: Single
Congr. District: 12
County: Washtenaw

Public Profile

In November 2009, it was announced that Becton Dickinson & Company (BD) had acquired HandyLab. HandyLab was in the business of developing and manufacturing portable, low-cost nucleic acid and protein-based analysis systems. The patented, self-contained microfluidic systems are capable of integrating and automating multiple laboratory processes on a single chip. The company focuses on applications requiring a high degree of sensitivity, specificity and speed in testing capabilities. HandyLab's microfluidic systems use only nanoliters of reagents, making it a cost-effective alternative to traditional laboratory testing. In addition, the disposable, single-use cartridges can be manufactured inexpensively and used to perform a wide variety of bio-assays. Designed for point-of-service and field use, minimally-skilled personnel can perform tests and analysis on raw clinical specimens in a portable unit in less than 30 minutes. The firm has multiple collbaorations with major players.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
2.5M-5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
25-49

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2003 2 NIH $340,000
Project Title: Nanoliter Device for Hepatitis C Detection
2002 1 NIH $100,000
Project Title: Development of sample prep device for bedside GBS test

Key People / Management

  Michael Farmer -- President

  Jeffrey S Williams -- President and Chief Executive Officer

  Sundaresh N Brahmasandra -- Co-founder and Vice President of Product Development

  Betty B Wu